Cao, Liyun <br/><br/>
Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling.  [electronic resource] 

 -  Carcinogenesis  Oct 2008 
 - 1893-900 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1460-2180 
<br/><br/><label>Standard No.: </label>10.1093/carcin/bgn158  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Caspase 9--metabolism<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Cisplatin--pharmacology<br/>Female<br/>GTP-Binding Proteins<br/>Humans<br/>Isoxazoles--pharmacology<br/>NF-kappa B--metabolism<br/>Neoplasms, Glandular and Epithelial--drug therapy<br/>Ovarian Neoplasms--drug therapy<br/>Protein Glutamine gamma Glutamyltransferase 2<br/>Signal Transduction<br/>Transglutaminases--analysis<br/>X-Linked Inhibitor of Apoptosis Protein--metabolism